Skip Nav Destination
Issues
1 May 2016
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
Research Articles
Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm
Xiangqing Sun; Robert C. Elston; Jill S. Barnholtz-Sloan; Gary W. Falk; William M. Grady; Ashley Faulx; Sumeet K. Mittal; Marcia Canto; Nicholas J. Shaheen; Jean S. Wang; Prasad G. Iyer; Julian A. Abrams; Ye D. Tian; Joseph E. Willis; Kishore Guda; Sanford D. Markowitz; Apoorva Chandar; James M. Warfe; Wendy Brock; Amitabh Chak
Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States
Anala Gossai; Tim Waterboer; Heather H. Nelson; Jennifer A. Doherty; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F. Farzan; Brock C. Christensen; Anne G. Hoen; Ann E. Perry; Michael Pawlita; Margaret R. Karagas
Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer
Ethan M. Lange; Jessica V. Ribado; Kimberly A. Zuhlke; Anna M. Johnson; Gregory R. Keele; Jin Li; Yunfei Wang; Qing Duan; Ge Li; Zhengrong Gao; Yun Li; Jianfeng Xu; S. Lilly Zheng; Kathleen A. Cooney
Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors
Joseph L. Usset; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Rama Raghavan; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Jonathan P. Tyrer; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Valerie McGuire; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Weiva Sieh; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Penelope Webb; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Jenny Chang-Claude; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Anja Rudolph; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Hoda Anton-Culver; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Andrew Berchuck; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Louise Brinton; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Julie M. Cunningham; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Anna DeFazio; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Jennifer A. Doherty; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Robert P. Edwards; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Simon A. Gayther; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Aleksandra Gentry-Maharaj; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Marc T. Goodman; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Estrid Høgdall; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Allan Jensen; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Sharon E. Johnatty; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Lambertus A. Kiemeney; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Susanne K. Kjaer; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Melissa C. Larson; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Galina Lurie; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Leon Massuger; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Usha Menon; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Francesmary Modugno; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Kirsten B. Moysich; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Roberta B. Ness; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Malcolm C. Pike; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Susan J. Ramus; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Mary Anne Rossing; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Joseph Rothstein; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Honglin Song; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Pamela J. Thompson; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; David J. van den Berg; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Robert A. Vierkant; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Shan Wang-Gohrke; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Nicolas Wentzensen; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Alice S. Whittemore; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Lynne R. Wilkens; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Anna H. Wu; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Hannah Yang; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Celeste Leigh Pearce; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Joellen M. Schildkraut; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Paul Pharoah; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Ellen L. Goode; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study; Brooke L. Fridley; on behalf of Ovarian Cancer Association Consortium and the Australian Cancer Study
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.